DRW Holdings »

Monte Rosa Therapeutics shares owned by DRW Holdings

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by DRW Holdings from 13F filings

Historical chart of DRW Holdings investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by DRW Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by DRW Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $235k 14k 16.45

More positions owned by DRW Holdings

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
iShares Russell 2000 Index Call Option (IWM)
NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Alphabet Inc Class A cs Call Option (GOOGL)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Tesla Motors Call Option (TSLA)
Asml Holding N V N Y Registry Shs Call Option (ASML)
Astrazeneca Plc Each Ads Representing 1/2 Of An Or Ordinary Share Call Option (AZN)
Advanced Micro Devices Call Option (AMD)
Ishares Core Msci Emkt (IEMG)
Facebook Inc cl a Call Option (META)
Vestas Put Option (VWSYF)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr China Lg-cap Etf (FXI)

View all positions for DRW Holdings

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
Vanguard Group
Braidwell
Versant Venture Management
Vanguard Capital Management
State Street Corporation
Aisling Capital Management
Geode Capital Management
American Century Companies

View all funds holding Monte Rosa Therapeutics